Have a question?
Please get in touch with our team in case of any queries
THE GLOBAL FETAL MONITORING MARKET SIZE IS EXPECTED TO REACH USD 6.17 BILLION BY 2029 FROM USD 3.94 BILLION IN 2023, GROWING AT A CAGR OF 7.74% DURING THE FORECAST PERIOD.
The Fetal Monitoring Market Size, Share, & Trends Analysis Report By
- Product Type: Ultrasound Devices, Electronic Maternal/Fetal Monitors, Fetal Electrodes, Fetal Doppler, Uterine Contraction Monitors, Telemetry Devices, and Others
- Portability: Portable and Non-Portable
- Method: Non-Invasive and Invasive
- Application: Antepartum and Intrapartum
- End-user: Hospitals, Obstetrics & Gynecology Clinics, and Others
- Geography: North America, Europe, APAC, Latin America, and Middle East & Africa
Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2024–2029.
This report includes market data points, ranging from trend
analyses to market estimates & forecasts that you can customize
FETAL MONITORING MARKET REPORT SCOPE
| REPORT ATTRIBUTE | DETAILS |
|---|---|
| Market Size (2029) | USD 6.17 Billion |
| Market Size (2023) | USD 3.94 Billion |
| CAGR (2023-2029) | 7.74% |
| HISTORIC YEAR | 2020-2022 |
| BASE YEAR | 2023 |
| FORECAST YEAR | 2024-2029 |
| SEGMENTS BY | Product Type, Portability, Method, Application, End-user, and Geography |
| GEOGRAPHIC ANALYSIS | North America, Europe, APAC, Latin America, and Middle East & Africa |
| KEY PLAYERS | Cardinal Health, CONTEC MEDICAL SYSTEMS, GE Healthcare, Koninklijke Philips, and Siemens Healthineers |
MARKET OVERVIEW
The global fetal monitoring market was valued at USD 3.94 billion in 2023 and is expected to reach USD 6.17 billion by 2029, growing at a CAGR of 7.74% during the forecast period. The market is experiencing dynamic growth, driven by technological advancements, increasing awareness of prenatal care, and rising incidences of high-risk pregnancies. As the market evolves, several key premium insights provide a deeper understanding of its current and future trajectory. Continuous technology innovation is one of the most significant drivers of the fetal monitoring market. Recent advancements have led to the developing of more sophisticated and user-friendly monitoring devices. Moreover, the shift towards non-invasive monitoring techniques is another critical trend in the market. Non-invasive methods, such as Doppler ultrasound and external fetal monitoring, are preferred by both patients and healthcare providers due to their safety, comfort, and ease of use. These methods reduce the risk of complications associated with invasive procedures and are particularly important in cases requiring frequent monitoring.
The increasing prevalence of high-risk pregnancies, driven by factors such as advanced maternal age, pre-existing health conditions, and lifestyle-related issues, is fueling demand for advanced fetal monitoring solutions. High-risk pregnancies require more frequent and intensive monitoring to ensure the health and safety of both mother and fetus. As a result, healthcare providers are investing in state-of-the-art fetal monitoring systems that offer real-time data, advanced diagnostics, and remote monitoring capabilities. These systems are designed to detect and respond to potential complications early, improving outcomes and reducing the risk of adverse events.
While the fetal monitoring market is well-established in developed regions such as North America and Europe, emerging markets, including APAC, Latin America, and Middle East & Africa, have significant growth potential. These regions are witnessing a rise in healthcare infrastructure investments, increasing maternal and fetal health awareness, and a growing middle class with greater access to healthcare services. Also, the regulatory environment plays a crucial role in shaping the fetal monitoring market. Companies must navigate complex regulatory requirements to bring new products to market, particularly in regions with stringent healthcare regulations, such as the United States and Europe. Obtaining regulatory approval can be lengthy and costly, but it is essential for ensuring product safety and efficacy.
In addition to regulatory challenges, the reimbursement landscape is another critical factor influencing market dynamics. In many countries, healthcare providers are reimbursed for fetal monitoring services, but reimbursement rates and policies can vary widely. Companies must stay informed about changes in reimbursement policies and adapt their strategies to ensure their products remain accessible and affordable for healthcare providers and patients.
Rapid technological advancements, increasing demand for non-invasive monitoring solutions, and a growing focus on high-risk pregnancies characterize the fetal monitoring market. While the market presents numerous growth opportunities, it faces challenges such as geographic disparities, regulatory hurdles, and high costs. Companies that can innovate, expand into emerging markets, and address the specific needs of healthcare providers and patients will be well-positioned to succeed in this dynamic and evolving market. The premium insights outline provides a roadmap for stakeholders looking to capitalize on the opportunities and navigate the global fetal monitoring market challenges.
MARKET TRENDS & DRIVERS
Integration of AI & ML in Fetal Monitoring
Integrating AI and ML in fetal monitoring opens new opportunities and sets transformative trends in the global market. These technologies enhance the accuracy, efficiency, and accessibility of prenatal care, leading to better outcomes for mothers and babies. For instance, AI and ML facilitate personalized prenatal care by analyzing patient data to tailor monitoring and treatment plans. Personalized care improves patient outcomes by addressing each patient's specific needs and risks. For instance, AI can recommend customized monitoring schedules based on a mother’s medical history and current health status. As AI and ML continue to evolve, they promise to revolutionize fetal monitoring further, making it more predictive, personalized, and proactive.
Growing Significance of Remote Fetal Monitoring
Remote fetal monitoring is revolutionizing prenatal care by providing accessible, convenient, and continuous monitoring of fetal health. The growing significance of these technologies is evident in their ability to enhance maternal and fetal outcomes, empower expectant mothers, and reduce healthcare disparities. The global fetal monitoring market is poised for significant growth, driven by the expansion of telehealth services, advancements in wearable devices, and the integration of big data and AI. Moreover, integrating big data and AI in remote fetal monitoring presents significant opportunities for predictive analytics and personalized care.
Manufacturers Focus on Developing Portable, Wireless, and Advanced Fetal Monitors
The focus on developing portable, wireless, and advanced fetal monitors has significantly shaped the global fetal monitoring market. These innovations offer numerous benefits, including enhanced mobility, improved comfort, and better integration with telemedicine platforms. Adopting advanced features such as AI, data analytics, and non-invasive monitoring techniques further drives market growth. As the demand for remote monitoring and comprehensive prenatal care continues to rise, manufacturers are well-positioned to capitalize on these opportunities, ultimately improving maternal and fetal health outcomes worldwide.
Growing Awareness and Demand for Prenatal Care
The growing awareness and demand for prenatal care drive the global fetal monitoring market. Factors such as rising awareness of prenatal health, technological advancements, the increasing prevalence of high-risk pregnancies, government initiatives, and the growing demand for home-based monitoring solutions contribute to the market's expansion. As expectant parents and healthcare providers continue to prioritize the health and well-being of the mother and fetus, the demand for advanced and reliable fetal monitoring systems is expected to remain robust, fueling further growth in the market.
Rising Number of Preterm Births & Increasing Adoption of Infertility Treatment
The rising number of preterm births and the increasing adoption of infertility treatments are significant drivers of the global fetal monitoring market. The demand for advanced, reliable, and efficient fetal monitoring systems will grow more during the forecast period. Technological advancements and supportive healthcare policies will be crucial in meeting this demand and ensuring better health outcomes for mothers and their babies. The future of fetal monitoring looks promising, with continuous innovations set to enhance prenatal care and address the challenges posed by high-risk pregnancies.
New Product Launches
The continuous launch of new and innovative products is dynamically shaping the global fetal monitoring market. Technological advancements, regulatory approvals, strategic collaborations, and a focus on enhancing patient experience drive the market forward. As these new products address evolving clinical needs and improve accessibility to advanced monitoring solutions, they are poised to impact maternal and fetal health outcomes worldwide significantly. The future of fetal monitoring looks promising, with ongoing innovation paving the way for safer, more efficient, and more comprehensive care for expectant mothers and their babies.
SEGMENTATION INSIGHTS
INSIGHTS BY PRODUCT TYPE
The global fetal monitoring market by product type is segmented into ultrasound devices, electronic maternal/fetal monitors, fetal electrodes, fetal doppler, uterine contraction monitors, telemetry devices, and others. The ultrasound devices segment holds the most significant global market share in 2023. Ultrasound devices are one of the most commonly used tools in fetal monitoring. These devices utilize high-frequency sound waves to create images of the fetus inside the womb, allowing healthcare providers to assess fetal development, check for abnormalities, and monitor the fetus’s growth and position. Furthermore, one of the most significant advancements in ultrasound technology is the development of 3D and 4D ultrasound. While traditional 2D ultrasound provides flat, two-dimensional images, 3D ultrasound generates three-dimensional images, offering a more detailed view of the fetus. 4D ultrasound adds dimension to time by creating real-time video images of fetal movements. These technologies allow for more detailed assessments of fetal anatomy and can enhance the detection of congenital anomalies.
INSIGHTS BY PORTABILITY
Portable portability holds the most significant share of the global fetal monitoring market in 2023. Portable fetal monitoring devices are compact, lightweight, and designed for mobility, allowing them to be used in various settings, including hospitals, clinics, home-care environments, and even during patient transport. Portable devices enable healthcare providers to monitor fetal well-being in diverse environments, including remote or underserved areas where access to healthcare facilities may be limited. With the increasing emphasis on patient-centered care, portable devices facilitate monitoring in home-care settings, allowing expectant mothers to undergo routine checks without frequent hospital visits.
INSIGHTS BY METHOD
The global fetal monitoring market by method is segmented into non-invasive and invasive. The non-invasive segment holds the largest market share in 2023. Non-invasive methods include ultrasound, external fetal monitoring, and fetal Doppler. These methods are generally preferred for routine monitoring due to their safety, ease of use, and ability to provide real-time data without direct contact with the fetus. Moreover, non-invasive fetal monitoring eliminates the risks associated with invasive procedures, such as infections, bleeding, or injury to the fetus. This makes it a safer option for the mother and the baby, particularly in routine monitoring or low-risk pregnancies. Furthermore, invasive methods include internal fetal monitoring and fetal scalp blood sampling. These techniques are used when more accurate and detailed information is needed, particularly in high-risk pregnancies or labor scenarios where non-invasive methods may be insufficient.
INSIGHTS BY APPLICATION
The antepartum application holds the largest share of the global fetal monitoring market. Antepartum fetal monitoring refers to assessing fetal well-being before the onset of labor. This type of monitoring aims to identify any potential issues that could affect the fetus and allows for early intervention to prevent complications. And intrapartum fetal monitoring refers to assessing fetal well-being during labor and delivery. This monitoring is crucial for detecting signs of fetal distress or complications that may arise during the birthing process. Furthermore, the choice of monitoring techniques and methods depends on the clinical situation, the risk level of the pregnancy, and the healthcare provider's judgment. Together, these monitoring strategies improve maternal and fetal outcomes by allowing timely interventions and informed decision-making throughout the pregnancy and delivery.
INSIGHTS BY END-USER
The global fetal monitoring market by end-user is segmented into hospitals, obstetrics & gynecology clinics, and others. In 2023, hospitals held the most extensive segmental share. Hospitals are the primary end-users of fetal monitoring systems, particularly during labor and delivery. They are equipped with the most advanced and comprehensive fetal monitoring technologies, designed to handle a wide range of situations, from routine monitoring to high-risk pregnancies. Hospitals typically have access to the latest and most sophisticated fetal monitoring equipment, including external and internal monitors. They may also use additional technologies such as ultrasound machines, central monitoring systems, and integrated patient management systems to store and analyze data in real time.
Furthermore, OB-GYN clinics frequently perform routine fetal monitoring during prenatal visits to check the fetal heart rate and overall well-being. Doppler ultrasound devices are commonly used for these purposes, offering a non-invasive way to monitor the fetus's health. Clinics often provide a more personalized and patient-centered approach to fetal monitoring. The settings are generally less clinical than hospitals, offering a more comfortable environment for expectant mothers. Also, fetal monitoring is increasingly used in other settings such as home care, imaging centers, and fertility centers. Each of these environments offers unique applications for fetal monitoring.
GEOGRAPHICAL ANALYSIS
The global fetal monitoring market is geographically diverse, with varying levels of market penetration, adoption of technology, and growth potential across different regions. The market dynamics are shaped by factors such as healthcare infrastructure, economic development, awareness of prenatal care, regulatory environments, and the prevalence of high-risk pregnancies. North America, particularly the U.S., is one of the largest and most mature markets for fetal monitoring. The region benefits from advanced healthcare infrastructure, high awareness of prenatal care, and significant investments in medical technology. North America held over 46% of the global fetal monitoring market share and dominated the global market in 2023.
Europe is another significant fetal monitoring market, with well-established healthcare systems and a strong focus on maternal and child health. The market is characterized by high adoption rates of advanced fetal monitoring technologies, particularly in Western Europe. The European market has evolved significantly, driven by technological advancements, growing maternal and fetal health awareness, and supportive healthcare policies. Furthermore, the APAC fetal monitoring market is rapidly growing, driven by large populations, increasing healthcare expenditures, and improving healthcare infrastructure in many countries. Also, Latin America and Middle East & Africa are emerging in the global fetal monitoring market, with countries like Brazil, Mexico, and Argentina leading the way. The region is experiencing growth in healthcare infrastructure and increasing awareness of prenatal care. While growth potential exists in urban and economically developed areas, rural regions face substantial challenges.
COMPETITIVE LANDSCAPE
The global fetal monitoring market is characterized by intense competition among players, including established multinational corporations, emerging companies, and local firms. This competition is driven by the need to innovate, the increasing demand for advanced maternal and fetal health solutions, and the continuous push to expand market share across different regions. Some of the key players in the global fetal monitoring market are Cardinal Health, CONTEC MEDICAL SYSTEMS, GE Healthcare, Koninklijke Philips, and Siemens Healthineers.
Further, companies in the global fetal monitoring market employ various competitive strategies to maintain and expand their market positions. These strategies include product innovation, strategic partnerships and acquisitions, geographic expansion, and competitive pricing. For instance, mergers and acquisitions and strategic partnerships are common strategies in the market, enabling companies to expand their product portfolios, enter new markets, and gain access to new technologies. Players like GE Healthcare have engaged in strategic acquisitions to strengthen their market positions. By acquiring smaller companies with innovative technologies, these giants can quickly integrate new products into their portfolios and expand their customer base.
SNAPSHOT
The global fetal monitoring market size is expected to grow at a CAGR of approximately 7.74% from 2023 to 2029.
The following factors are likely to contribute to the growth of the global fetal monitoring market during the forecast period:
- Growing Awareness and Demand for Prenatal Care
- Growing Advancements & Innovations in Fetal Monitoring Technologies
- Rising Number of Preterm Births & Increasing Adoption of Infertility Treatment
- New Product Launches
Base Year: 2023
Forecast Year: 2024-2029
The report considers the present scenario of the global fetal monitoring market and its market dynamics for 2024−2029. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the industry. It also profiles and analyzes leading companies and several other prominent companies operating in the industry.
Key Company Profiles
- Cardinal Health
- Business Overview
- Product Offerings
- Key Strategies
- Key Strengths
- Key Opportunities
- CONTEC MEDICAL SYSTEMS
- GE Healthcare
- Koninklijke Philips
- Siemens Healthineers
Other Prominent Vendors
- Advanced Instrumentations
- Business Overview
- Product Offerings
- Atom Medical
- Biolight Healthcare
- Bistos
- BPL Medical Technologies
- BRAEL
- ChoiceMMed
- EDAN Instruments
- France Création & Comed
- General Meditech
- Gima S.p.A.
- Greatmade Tech
- Huntleigh Healthcare
- JUMPER
- MEDGYN PRODUCTS
- Medi Waves
- MEDIANA
- medical Econet
- Meditech Equipment
- Moretti S.p.A.
- Narang Medical
- Newman Medical
- Promed Technology
- PROMISE TECHNOLOGY
- Shenzhen Aeon Technology
- Shenzhen Bestman Instrument
- Shenzhen Luckcome Technology
- SHENZHEN UNICARE ELECTRONIC
- Spengler Holtex Group
- Surgitek
- Technocare Medisystems
- The Cooper Companies
- TOITU
- TRISMED
- Ultrasound Technologies
- YONKER
- Zhengzhou Dison Instrument and Meter Co.
Segmentation by Product Type
- Ultrasound Devices
- Electronic Maternal/Fetal Monitors
- Fetal Electrodes
- Fetal Doppler
- Uterine Contraction Monitors
- Telemetry Devices
- Others
Segmentation by Portability
- Portable
- Non-Portable
Segmentation by Method
- Non-Invasive
- Invasive
Segmentation by Application
- Antepartum
- Intrapartum
Segmentation by End-user
- Hospitals
- Obstetrics & Gynecology Clinics
- Others
Segmentation by Geography
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- The U.K.
- Italy
- Spain
- Russia
- Netherlands
- APAC
- China
- Japan
- India
- South Korea
- Australia
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Middle East & Africa
- Turkey
- Saudi Arabia
- South Africa
- UAE
Frequently Asked Questions
What is the growth rate of the global fetal monitoring market?
How big is the global fetal monitoring market?
Which region dominates the global fetal monitoring market share?
What are the significant trends in the fetal monitoring market?
Who are the key players in the global fetal monitoring market?
EXHIBIT 1 MARKET SIZE CALCULATION APPROACH 2023
EXHIBIT 2 GLOBAL FETAL MONITORING MARKET BY GEOGRAPHY: MARKET SHARE 2023 & 2029 (%)
EXHIBIT 3 GLOBAL FETAL MONITORING MARKET BY PRODUCT TYPE: MARKET SHARE 2023 & 2029 (%)
EXHIBIT 4 GLOBAL FETAL MONITORING MARKET BY PORTABILITY: MARKET SHARE 2023 & 2029 (%)
EXHIBIT 5 GLOBAL FETAL MONITORING MARKET BY METHOD: MARKET SHARE 2023 & 2029 (%)
EXHIBIT 6 GLOBAL FETAL MONITORING MARKET BY APPLICATION: MARKET SHARE 2023 & 2029 (%)
EXHIBIT 7 GLOBAL FETAL MONITORING MARKET BY END-USER: MARKET SHARE 2023 & 2029 (%)
EXHIBIT 8 IMPACT OF INTEGRATION OF AI & ML IN FETAL MONITORING
EXHIBIT 9 IMPACT OF GROWTH IN SIGNIFICANCE OF REMOTE FETAL MONITORING
EXHIBIT 10 IMPACT OF GROWTH IN GOVERNMENT INITIATIVES & COLLABORATIONS FOR RESEARCH BY HEALTH AGENCIES
EXHIBIT 11 IMPACT OF MANUFACTURERS FOCUS ON DEVELOPING PORTABLE, WIRELESS, AND ADVANCED FETAL MONITORS
EXHIBIT 12 IMPACT OF GROWTH IN AWARENESS AND DEMAND FOR PRENATAL CARE
EXHIBIT 13 IMPACT OF GROWTH IN ADVANCES & INNOVATIONS IN FETAL MONITORING TECHNOLOGIES
EXHIBIT 14 IMPACT OF RISE IN NUMBER OF PRETERM BIRTHS & ADOPTION OF INFERTILITY TREATMENT
EXHIBIT 15 IMPACT OF NEW PRODUCT LAUNCHES
EXHIBIT 16 IMPACT OF COMMON ERRORS IN FETAL HEART MONITORING
EXHIBIT 17 IMPACT OF HIGH COST OF FETAL MONITORING EQUIPMENT
EXHIBIT 18 IMPACT OF AVAILABILITY OF REFURBISHED EQUIPMENT
EXHIBIT 19 GLOBAL FETAL MONITORING MARKET 2020–2029 ($ MILLION)
EXHIBIT 20 FIVE FORCES ANALYSIS 2023
EXHIBIT 21 INCREMENTAL GROWTH BY PRODUCT TYPE 2023 & 2029
EXHIBIT 22 GLOBAL FETAL MONITORING MARKET BY PRODUCT TYPE 2023-2029: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 23 GLOBAL FETAL MONITORING MARKET BY PRODUCT TYPE 2023-2029: ABSOLUTE GROWTH (%)
EXHIBIT 24 GLOBAL ULTRASOUND DEVICES FETAL MONITORING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 25 GLOBAL ULTRASOUND DEVICES FETAL MONITORING MARKET 2020-2029 ($ MILLION)
EXHIBIT 26 GLOBAL ELECTRONIC MATERNAL/FETAL MONITORING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 27 GLOBAL ELECTRONIC MATERNAL/FETAL MONITORING MARKET 2020-2029 ($ MILLION)
EXHIBIT 28 GLOBAL FETAL ELECTRODES MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 29 GLOBAL FETAL ELECTRODES MARKET 2020-2029 ($ MILLION)
EXHIBIT 30 GLOBAL FETAL DOPPLER MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 31 GLOBAL FETAL DOPPLER MARKET 2020-2029 ($ MILLION)
EXHIBIT 32 GLOBAL UTERINE CONTRACTION FETAL MONITORING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 33 GLOBAL UTERINE CONTRACTION FETAL MONITORING MARKET 2020-2029 ($ MILLION)
EXHIBIT 34 GLOBAL TELEMETRY DEVICES FETAL MONITORING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 35 GLOBAL TELEMETRY DEVICES FETAL MONITORING MARKET 2020-2029 ($ MILLION)
EXHIBIT 36 GLOBAL OTHERS FETAL MONITORING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 37 GLOBAL OTHERS FETAL MONITORING MARKET 2020-2029 ($ MILLION)
EXHIBIT 38 INCREMENTAL GROWTH BY PORTABILITY 2023 & 2029
EXHIBIT 39 GLOBAL FETAL MONITORING MARKET BY PORTABILITY 2023-2029: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 40 GLOBAL FETAL MONITORING MARKET BY PORTABILITY 2023-2029: ABSOLUTE GROWTH (%)
EXHIBIT 41 GLOBAL PORTABLE FETAL MONITORING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 42 GLOBAL PORTABLE FETAL MONITORING MARKET 2020-2029 ($ MILLION)
EXHIBIT 43 GLOBAL NON-PORTABLE FETAL MONITORING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 44 GLOBAL NON-PORTABLE FETAL MONITORING MARKET 2020-2029 ($ MILLION)
EXHIBIT 45 INCREMENTAL GROWTH BY METHOD 2023 & 2029
EXHIBIT 46 GLOBAL FETAL MONITORING MARKET BY METHOD 2023-2029: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 47 GLOBAL FETAL MONITORING MARKET BY METHOD 2023-2029: ABSOLUTE GROWTH (%)
EXHIBIT 48 GLOBAL NON-INVASIVE FETAL MONITORING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 49 GLOBAL NON-INVASIVE FETAL MONITORING MARKET 2020-2029 ($ MILLION)
EXHIBIT 50 GLOBAL INVASIVE FETAL MONITORING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 51 GLOBAL INVASIVE FETAL MONITORING MARKET 2020-2029 ($ MILLION)
EXHIBIT 52 INCREMENTAL GROWTH BY APPLICATION 2023 & 2029
EXHIBIT 53 GLOBAL FETAL MONITORING MARKET BY APPLICATION 2023-2029: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 54 GLOBAL FETAL MONITORING MARKET BY APPLICATION 2023-2029: ABSOLUTE GROWTH (%)
EXHIBIT 55 GLOBAL ANTEPARTUM FETAL MONITORING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 56 GLOBAL ANTEPARTUM FETAL MONITORING MARKET 2020-2029 ($ MILLION)
EXHIBIT 57 GLOBAL INTRAPARTUM FETAL MONITORING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 58 GLOBAL INTRAPARTUM FETAL MONITORING MARKET 2020-2029 ($ MILLION)
EXHIBIT 59 INCREMENTAL GROWTH BY END-USER 2023 & 2029
EXHIBIT 60 GLOBAL FETAL MONITORING MARKET BY END-USER 2023-2029: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 61 GLOBAL FETAL MONITORING MARKET BY END-USER 2023-2029: ABSOLUTE GROWTH (%)
EXHIBIT 62 GLOBAL HOSPITALS FETAL MONITORING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 63 GLOBAL HOSPITALS FETAL MONITORING MARKET 2020-2029 ($ MILLION)
EXHIBIT 64 GLOBAL OBSTETRICS & GYNECOLOGY CLINICS FETAL MONITORING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 65 GLOBAL OBSTETRICS & GYNECOLOGY CLINICS FETAL MONITORING MARKET 2020-2029 ($ MILLION)
EXHIBIT 66 GLOBAL OTHERS FETAL MONITORING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 67 GLOBAL OTHERS FETAL MONITORING MARKET 2020-2029 ($ MILLION)
EXHIBIT 68 INCREMENTAL GROWTH BY GEOGRAPHY 2023 & 2029
EXHIBIT 69 GLOBAL FETAL MONITORING MARKET BY GEOGRAPHY 2023-2029: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 70 GLOBAL FETAL MONITORING MARKET BY GEOGRAPHY 2023-2029: ABSOLUTE GROWTH (%)
EXHIBIT 71 NORTH AMERICA FETAL MONITORING MARKET: KEY COUNTRIES IN 2023 ($ MILLION)
EXHIBIT 72 NORTH AMERICA FETAL MONITORING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 73 NORTH AMERICA FETAL MONITORING MARKET 2020–2029 ($ MILLION)
EXHIBIT 74 INCREMENTAL GROWTH IN NORTH AMERICA 2023 & 2029
EXHIBIT 75 US FETAL MONITORING MARKET 2020–2029 ($ MILLION)
EXHIBIT 76 CANADA FETAL MONITORING MARKET 2020–2029 ($ MILLION)
EXHIBIT 77 EUROPE FETAL MONITORING MARKET: KEY COUNTRIES IN 2023 ($ MILLION)
EXHIBIT 78 EUROPE FETAL MONITORING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 79 EUROPE FETAL MONITORING MARKET 2020–2029 ($ MILLION)
EXHIBIT 80 INCREMENTAL GROWTH IN EUROPE 2023 & 2029
EXHIBIT 81 GERMANY FETAL MONITORING MARKET 2020–2029 ($ MILLION)
EXHIBIT 82 FRANCE FETAL MONITORING MARKET 2020–2029 ($ MILLION)
EXHIBIT 83 UK FETAL MONITORING MARKET 2020–2029 ($ MILLION)
EXHIBIT 84 ITALY FETAL MONITORING MARKET 2020–2029 ($ MILLION)
EXHIBIT 85 SPAIN FETAL MONITORING MARKET 2020–2029 ($ MILLION)
EXHIBIT 86 RUSSIA FETAL MONITORING MARKET 2020–2029 ($ MILLION)
EXHIBIT 87 NETHERLANDS FETAL MONITORING MARKET 2020–2029 ($ MILLION)
EXHIBIT 88 APAC FETAL MONITORING MARKET: KEY COUNTRIES IN 2023 ($ MILLION)
EXHIBIT 89 APAC FETAL MONITORING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 90 APAC FETAL MONITORING MARKET 2020–2029 ($ MILLION)
EXHIBIT 91 INCREMENTAL GROWTH IN APAC 2023 & 2029
EXHIBIT 92 CHINA FETAL MONITORING MARKET 2020–2029 ($ MILLION)
EXHIBIT 93 JAPAN FETAL MONITORING MARKET 2020–2029 ($ MILLION)
EXHIBIT 94 INDIA FETAL MONITORING MARKET 2020–2029 ($ MILLION)
EXHIBIT 95 SOUTH KOREA FETAL MONITORING MARKET 2020–2029 ($ MILLION)
EXHIBIT 96 AUSTRALIA FETAL MONITORING MARKET 2020–2029 ($ MILLION)
EXHIBIT 97 LATIN AMERICA FETAL MONITORING MARKET: KEY COUNTRIES IN 2023 ($ MILLION)
EXHIBIT 98 LATIN AMERICA FETAL MONITORING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 99 LATIN AMERICA FETAL MONITORING MARKET 2020–2029 ($ MILLION)
EXHIBIT 100 INCREMENTAL GROWTH IN LATIN AMERICA 2023 & 2029
EXHIBIT 101 BRAZIL FETAL MONITORING MARKET 2020–2029 ($ MILLION)
EXHIBIT 102 MEXICO FETAL MONITORING MARKET 2020–2029 ($ MILLION)
EXHIBIT 103 ARGENTINA FETAL MONITORING MARKET 2020–2029 ($ MILLION)
EXHIBIT 104 COLOMBIA FETAL MONITORING MARKET 2020–2029 ($ MILLION)
EXHIBIT 105 MIDDLE EAST & AFRICA FETAL MONITORING MARKET: KEY COUNTRIES IN 2023 ($ MILLION)
EXHIBIT 106 MIDDLE EAST & AFRICA FETAL MONITORING MARKET 2023-2029: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 107 MIDDLE EAST & AFRICA FETAL MONITORING MARKET 2020–2029 ($ MILLION)
EXHIBIT 108 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2023 & 2029
EXHIBIT 109 TURKEY FETAL MONITORING MARKET 2020–2029 ($ MILLION)
EXHIBIT 110 SAUDI ARABIA FETAL MONITORING MARKET 2020–2029 ($ MILLION)
EXHIBIT 111 SOUTH AFRICA FETAL MONITORING MARKET 2020–2029 ($ MILLION)
EXHIBIT 112 UAE FETAL MONITORING MARKET 2020–2029 ($ MILLION)
EXHIBIT 113 VENDORS OFFERING FETAL MONITORING PRODUCTS: MARKET DOMINANCE ANALYSIS
EXHIBIT 114 VENDORS OFFERING COMMERCIAL FETAL MONITORING PRODUCTS: CAPABILITIES & EXPERTISE ASSESSMENT
EXHIBIT 115 KEY CAVEATS
LIST OF TABLES
TABLE 1 GLOBAL ULTRASOUND DEVICES FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 2 GLOBAL ULTRASOUND DEVICES FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 3 GLOBAL ELECTRONIC MATERNAL/FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 4 GLOBAL ELECTRONIC MATERNAL/FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 5 GLOBAL FETAL ELECTRODES MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 6 GLOBAL FETAL ELECTRODES MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 7 GLOBAL FETAL DOPPLER MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 8 GLOBAL FETAL DOPPLER MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 9 GLOBAL UTERINE CONTRACTION FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 10 GLOBAL UTERINE CONTRACTION FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 11 GLOBAL TELEMETRY DEVICES FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 12 GLOBAL TELEMETRY DEVICES FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 13 GLOBAL OTHERS FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 14 GLOBAL OTHERS FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 15 GLOBAL PORTABLE FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 16 GLOBAL PORTABLE FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 17 GLOBAL NON-PORTABLE FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 18 GLOBAL NON-PORTABLE FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 19 GLOBAL NON-INVASIVE FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 20 GLOBAL NON-INVASIVE FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 21 GLOBAL INVASIVE FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 22 GLOBAL INVASIVE FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 23 GLOBAL ANTEPARTUM FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 24 GLOBAL ANTEPARTUM FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 25 GLOBAL INTRAPARTUM FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 26 GLOBAL INTRAPARTUM FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 27 GLOBAL HOSPITALS FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 28 GLOBAL HOSPITALS FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 29 GLOBAL OBSTETRICS & GYNECOLOGY CLINICS FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 30 GLOBAL OBSTETRICS & GYNECOLOGY CLINICS FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 31 GLOBAL OTHERS FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 32 GLOBAL OTHERS FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 33 NORTH AMERICA FETAL MONITORING MARKET BY PRODUCT TYPE 2023−2029 ($ MILLION)
TABLE 34 NORTH AMERICA FETAL MONITORING MARKET BY PRODUCT TYPE 2023−2029 (%)
TABLE 35 NORTH AMERICA FETAL MONITORING MARKET BY PORTABILITY 2023−2029 ($ MILLION)
TABLE 36 NORTH AMERICA FETAL MONITORING MARKET BY PORTABILITY 2023−2029 (%)
TABLE 37 NORTH AMERICA FETAL MONITORING MARKET BY METHOD 2023−2029 ($ MILLION)
TABLE 38 NORTH AMERICA FETAL MONITORING MARKET BY METHOD 2023−2029 (%)
TABLE 39 NORTH AMERICA FETAL MONITORING MARKET BY APPLICATION 2023−2029 ($ MILLION)
TABLE 40 NORTH AMERICA FETAL MONITORING MARKET BY APPLICATION 2023−2029 (%)
TABLE 41 NORTH AMERICA FETAL MONITORING MARKET BY END-USER 2023−2029 ($ MILLION)
TABLE 42 NORTH AMERICA FETAL MONITORING MARKET BY END-USER 2023−2029 (%)
TABLE 43 EUROPE FETAL MONITORING MARKET BY PRODUCT TYPE 2023−2029 ($ MILLION)
TABLE 44 EUROPE FETAL MONITORING MARKET BY PRODUCT TYPE 2023−2029 (%)
TABLE 45 EUROPE FETAL MONITORING MARKET BY PORTABILITY 2023−2029 ($ MILLION)
TABLE 46 EUROPE FETAL MONITORING MARKET BY PORTABILITY 2023−2029 (%)
TABLE 47 EUROPE FETAL MONITORING MARKET BY METHOD 2023−2029 ($ MILLION)
TABLE 48 EUROPE FETAL MONITORING MARKET BY METHOD 2023−2029 (%)
TABLE 49 EUROPE FETAL MONITORING MARKET BY APPLICATION 2023−2029 ($ MILLION)
TABLE 50 EUROPE FETAL MONITORING MARKET BY APPLICATION 2023−2029 (%)
TABLE 51 EUROPE FETAL MONITORING MARKET BY END-USER 2023−2029 ($ MILLION)
TABLE 52 EUROPE FETAL MONITORING MARKET BY END-USER 2023−2029 (%)
TABLE 53 APAC FETAL MONITORING MARKET BY PRODUCT TYPE 2023−2029 ($ MILLION)
TABLE 54 APAC FETAL MONITORING MARKET BY PRODUCT TYPE 2023−2029 (%)
TABLE 55 APAC FETAL MONITORING MARKET BY PORTABILITY 2023−2029 ($ MILLION)
TABLE 56 APAC FETAL MONITORING MARKET BY PORTABILITY 2023−2029 (%)
TABLE 57 APAC FETAL MONITORING MARKET BY METHOD 2023−2029 ($ MILLION)
TABLE 58 APAC FETAL MONITORING MARKET BY METHOD 2023−2029 (%)
TABLE 59 APAC FETAL MONITORING MARKET BY APPLICATION 2023−2029 ($ MILLION)
TABLE 60 APAC FETAL MONITORING MARKET BY APPLICATION 2023−2029 (%)
TABLE 61 APAC FETAL MONITORING MARKET BY END-USER 2023−2029 ($ MILLION)
TABLE 62 APAC FETAL MONITORING MARKET BY END-USER 2023−2029 (%)
TABLE 63 LATIN AMERICA FETAL MONITORING MARKET BY PRODUCT TYPE 2023−2029 ($ MILLION)
TABLE 64 LATIN AMERICA FETAL MONITORING MARKET BY PRODUCT TYPE 2023−2029 (%)
TABLE 65 LATIN AMERICA FETAL MONITORING MARKET BY PORTABILITY 2023−2029 ($ MILLION)
TABLE 66 LATIN AMERICA FETAL MONITORING MARKET BY PORTABILITY 2023−2029 (%)
TABLE 67 LATIN AMERICA FETAL MONITORING MARKET BY METHOD 2023−2029 ($ MILLION)
TABLE 68 LATIN AMERICA FETAL MONITORING MARKET BY METHOD 2023−2029 (%)
TABLE 69 LATIN AMERICA FETAL MONITORING MARKET BY APPLICATION 2023−2029 ($ MILLION)
TABLE 70 LATIN AMERICA FETAL MONITORING MARKET BY APPLICATION 2023−2029 (%)
TABLE 71 LATIN AMERICA FETAL MONITORING MARKET BY END-USER 2023−2029 ($ MILLION)
TABLE 72 LATIN AMERICA FETAL MONITORING MARKET BY END-USER 2023−2029 (%)
TABLE 73 MIDDLE EAST & AFRICA FETAL MONITORING MARKET BY PRODUCT TYPE 2023−2029 ($ MILLION)
TABLE 74 MIDDLE EAST & AFRICA FETAL MONITORING MARKET BY PRODUCT TYPE 2023−2029 (%)
TABLE 75 MIDDLE EAST & AFRICA FETAL MONITORING MARKET BY PORTABILITY 2023−2029 ($ MILLION)
TABLE 76 MIDDLE EAST & AFRICA FETAL MONITORING MARKET BY PORTABILITY 2023−2029 (%)
TABLE 77 MIDDLE EAST & AFRICA FETAL MONITORING MARKET BY METHOD 2023−2029 ($ MILLION)
TABLE 78 MIDDLE EAST & AFRICA FETAL MONITORING MARKET BY METHOD 2023−2029 (%)
TABLE 79 MIDDLE EAST & AFRICA FETAL MONITORING MARKET BY APPLICATION 2023−2029 ($ MILLION)
TABLE 80 MIDDLE EAST & AFRICA FETAL MONITORING MARKET BY APPLICATION 2023−2029 (%)
TABLE 81 MIDDLE EAST & AFRICA FETAL MONITORING MARKET BY END-USER 2023−2029 ($ MILLION)
TABLE 82 MIDDLE EAST & AFRICA FETAL MONITORING MARKET BY END-USER 2023−2029 (%)
TABLE 83 CARDINAL HEALTH: MAJOR PRODUCT OFFERINGS
TABLE 84 CONTEC MEDICAL SYSTEMS: MAJOR PRODUCT OFFERINGS
TABLE 85 GE HEALTHCARE: MAJOR PRODUCT OFFERINGS
TABLE 86 KONINKLIJKE PHILIPS: MAJOR PRODUCT OFFERINGS
TABLE 87 SIEMENS HEALTHINEERS: MAJOR PRODUCT OFFERINGS
TABLE 88 ADVANCED INSTRUMENTATIONS: MAJOR PRODUCT OFFERINGS
TABLE 89 ATOM MEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 90 BIOLIGHT HEALTHCARE: MAJOR PRODUCT OFFERINGS
TABLE 91 BISTOS: MAJOR PRODUCT OFFERINGS
TABLE 92 BPL MEDICAL TECHNOLOGIES: MAJOR PRODUCT OFFERINGS
TABLE 93 BRAEL: MAJOR PRODUCT OFFERINGS
TABLE 94 CHOICEMMED: MAJOR PRODUCT OFFERINGS
TABLE 95 EDAN INSTRUMENTS: MAJOR PRODUCT OFFERINGS
TABLE 96 FRANCE CRÉATION & COMED: MAJOR PRODUCT OFFERINGS
TABLE 97 GENERAL MEDITECH: MAJOR PRODUCT OFFERINGS
TABLE 98 GIMA S.P.A.: MAJOR PRODUCT OFFERINGS
TABLE 99 GREATMADE TECH: MAJOR PRODUCT OFFERINGS
TABLE 100 HUNTLEIGH HEALTHCARE: MAJOR PRODUCT OFFERINGS
TABLE 101 JUMPER: MAJOR PRODUCT OFFERINGS
TABLE 102 MEDGYN PRODUCTS: MAJOR PRODUCT OFFERINGS
TABLE 103 MEDI WAVES: MAJOR PRODUCT OFFERINGS
TABLE 104 MEDIANA: MAJOR PRODUCT OFFERINGS
TABLE 105 MEDICAL ECONET: MAJOR PRODUCT OFFERINGS
TABLE 106 MEDITECH EQUIPMENT: MAJOR PRODUCT OFFERINGS
TABLE 107 MORETTI S.P.A.: MAJOR PRODUCT OFFERINGS
TABLE 108 NARANG MEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 109 NEWMAN MEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 110 PROMED TECHNOLOGY: MAJOR PRODUCT OFFERINGS
TABLE 111 PROMISE TECHNOLOGY: MAJOR PRODUCT OFFERINGS
TABLE 112 SHENZHEN AEON TECHNOLOGY: MAJOR PRODUCT OFFERINGS
TABLE 113 SHENZHEN BESTMAN INSTRUMENT: MAJOR PRODUCT OFFERINGS
TABLE 114 SHENZHEN LUCKCOME TECHNOLOGY: MAJOR PRODUCT OFFERINGS
TABLE 115 SHENZHEN UNICARE ELECTRONIC: MAJOR PRODUCT OFFERINGS
TABLE 116 SPENGLER HOLTEX GROUP: MAJOR PRODUCT OFFERINGS
TABLE 117 SURGITEK: MAJOR PRODUCT OFFERINGS
TABLE 118 TECHNOCARE MEDISYSTEMS: MAJOR PRODUCT OFFERINGS
TABLE 119 THE COOPER COMPANIES: MAJOR PRODUCT OFFERINGS
TABLE 120 TOITU: MAJOR PRODUCT OFFERINGS
TABLE 121 TRISMED: MAJOR PRODUCT OFFERINGS
TABLE 122 ULTRASOUND TECHNOLOGIES: MAJOR PRODUCT OFFERINGS
TABLE 123 YONKER: MAJOR PRODUCT OFFERINGS
TABLE 124 ZHENGZHOU DISON INSTRUMENT AND METER CO.: MAJOR PRODUCT OFFERINGS
TABLE 125 GLOBAL FETAL MONITORING MARKET BY PRODUCT TYPE 2023−2029 ($ MILLION)
TABLE 126 GLOBAL FETAL MONITORING MARKET BY PRODUCT TYPE 2023−2029 (%)
TABLE 127 NORTH AMERICA FETAL MONITORING MARKET BY PRODUCT TYPE 2023−2029 ($ MILLION)
TABLE 128 NORTH AMERICA FETAL MONITORING MARKET BY PRODUCT TYPE 2023−2029 (%)
TABLE 129 EUROPE FETAL MONITORING MARKET BY PRODUCT TYPE 2023−2029 ($ MILLION)
TABLE 130 EUROPE FETAL MONITORING MARKET BY PRODUCT TYPE 2023−2029 (%)
TABLE 131 APAC FETAL MONITORING MARKET BY PRODUCT TYPE 2023−2029 ($ MILLION)
TABLE 132 APAC FETAL MONITORING MARKET BY PRODUCT TYPE 2023−2029 (%)
TABLE 133 LATIN AMERICA FETAL MONITORING MARKET BY PRODUCT TYPE 2023−2029 ($ MILLION)
TABLE 134 LATIN AMERICA FETAL MONITORING MARKET BY PRODUCT TYPE 2023−2029 (%)
TABLE 135 MIDDLE EAST & AFRICA FETAL MONITORING MARKET BY PRODUCT TYPE 2023−2029 ($ MILLION)
TABLE 136 MIDDLE EAST & AFRICA FETAL MONITORING MARKET BY PRODUCT TYPE 2023−2029 (%)
TABLE 137 GLOBAL FETAL MONITORING MARKET BY PORTABILITY 2023−2029 ($ MILLION)
TABLE 138 GLOBAL FETAL MONITORING MARKET BY PORTABILITY 2023−2029 (%)
TABLE 139 NORTH AMERICA FETAL MONITORING MARKET BY PORTABILITY 2023−2029 ($ MILLION)
TABLE 140 NORTH AMERICA FETAL MONITORING MARKET BY PORTABILITY 2023−2029 (%)
TABLE 141 EUROPE FETAL MONITORING MARKET BY PORTABILITY 2023−2029 ($ MILLION)
TABLE 142 EUROPE FETAL MONITORING MARKET BY PORTABILITY 2023−2029 (%)
TABLE 143 APAC FETAL MONITORING MARKET BY PORTABILITY 2023−2029 ($ MILLION)
TABLE 144 APAC FETAL MONITORING MARKET BY PORTABILITY 2023−2029 (%)
TABLE 145 LATIN AMERICA FETAL MONITORING MARKET BY PORTABILITY 2023−2029 ($ MILLION)
TABLE 146 LATIN AMERICA FETAL MONITORING MARKET BY PORTABILITY 2023−2029 (%)
TABLE 147 MIDDLE EAST & AFRICA FETAL MONITORING MARKET BY PORTABILITY 2023−2029 ($ MILLION)
TABLE 148 MIDDLE EAST & AFRICA FETAL MONITORING MARKET BY PORTABILITY 2023−2029 (%)
TABLE 149 GLOBAL FETAL MONITORING MARKET BY METHOD 2023−2029 ($ MILLION)
TABLE 150 GLOBAL FETAL MONITORING MARKET BY METHOD 2023−2029 (%)
TABLE 151 NORTH AMERICA FETAL MONITORING MARKET BY METHOD 2023−2029 ($ MILLION)
TABLE 152 NORTH AMERICA FETAL MONITORING MARKET BY METHOD 2023−2029 (%)
TABLE 153 EUROPE FETAL MONITORING MARKET BY METHOD 2023−2029 ($ MILLION)
TABLE 154 EUROPE FETAL MONITORING MARKET BY METHOD 2023−2029 (%)
TABLE 155 APAC FETAL MONITORING MARKET BY METHOD 2023−2029 ($ MILLION)
TABLE 156 APAC FETAL MONITORING MARKET BY METHOD 2023−2029 (%)
TABLE 157 LATIN AMERICA FETAL MONITORING MARKET BY METHOD 2023−2029 ($ MILLION)
TABLE 158 LATIN AMERICA FETAL MONITORING MARKET BY METHOD 2023−2029 (%)
TABLE 159 MIDDLE EAST & AFRICA FETAL MONITORING MARKET BY METHOD 2023−2029 ($ MILLION)
TABLE 160 MIDDLE EAST & AFRICA FETAL MONITORING MARKET BY METHOD 2023−2029 (%)
TABLE 161 GLOBAL FETAL MONITORING MARKET BY APPLICATION 2023−2029 ($ MILLION)
TABLE 162 GLOBAL FETAL MONITORING MARKET BY APPLICATION 2023−2029 (%)
TABLE 163 NORTH AMERICA FETAL MONITORING MARKET BY APPLICATION 2023−2029 ($ MILLION)
TABLE 164 NORTH AMERICA FETAL MONITORING MARKET BY APPLICATION 2023−2029 (%)
TABLE 165 EUROPE FETAL MONITORING MARKET BY APPLICATION 2023−2029 ($ MILLION)
TABLE 166 EUROPE FETAL MONITORING MARKET BY APPLICATION 2023−2029 (%)
TABLE 167 APAC FETAL MONITORING MARKET BY APPLICATION 2023−2029 ($ MILLION)
TABLE 168 APAC FETAL MONITORING MARKET BY APPLICATION 2023−2029 (%)
TABLE 169 LATIN AMERICA FETAL MONITORING MARKET BY APPLICATION 2023−2029 ($ MILLION)
TABLE 170 LATIN AMERICA FETAL MONITORING MARKET BY APPLICATION 2023−2029 (%)
TABLE 171 MIDDLE EAST & AFRICA FETAL MONITORING MARKET BY APPLICATION 2023−2029 ($ MILLION)
TABLE 172 MIDDLE EAST & AFRICA FETAL MONITORING MARKET BY APPLICATION 2023−2029 (%)
TABLE 173 GLOBAL FETAL MONITORING MARKET BY END-USER 2023−2029 ($ MILLION)
TABLE 174 GLOBAL FETAL MONITORING MARKET BY END-USER 2023−2029 (%)
TABLE 175 NORTH AMERICA FETAL MONITORING MARKET BY END-USER 2023−2029 ($ MILLION)
TABLE 176 NORTH AMERICA FETAL MONITORING MARKET BY END-USER 2023−2029 (%)
TABLE 177 EUROPE FETAL MONITORING MARKET BY END-USER 2023−2029 ($ MILLION)
TABLE 178 EUROPE FETAL MONITORING MARKET BY END-USER 2023−2029 (%)
TABLE 179 APAC FETAL MONITORING MARKET BY END-USER 2023−2029 ($ MILLION)
TABLE 180 APAC FETAL MONITORING MARKET BY END-USER 2023−2029 (%)
TABLE 181 LATIN AMERICA FETAL MONITORING MARKET BY END-USER 2023−2029 ($ MILLION)
TABLE 182 LATIN AMERICA FETAL MONITORING MARKET BY END-USER 2023−2029 (%)
TABLE 183 MIDDLE EAST & AFRICA FETAL MONITORING MARKET BY END-USER 2023−2029 ($ MILLION)
TABLE 184 MIDDLE EAST & AFRICA FETAL MONITORING MARKET BY END-USER 2023−2029 (%)
TABLE 185 GLOBAL FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 186 GLOBAL FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 187 GLOBAL ULTRASOUND DEVICES FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 188 GLOBAL ULTRASOUND DEVICES FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 189 GLOBAL ELECTRONIC MATERNAL/FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 190 GLOBAL ELECTRONIC MATERNAL/FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 191 GLOBAL FETAL ELECTRODES MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 192 GLOBAL FETAL ELECTRODES MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 193 GLOBAL FETAL DOPPLER MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 194 GLOBAL FETAL DOPPLER MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 195 GLOBAL UTERINE CONTRACTION FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 196 GLOBAL UTERINE CONTRACTION FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 197 GLOBAL TELEMETRY DEVICES FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 198 GLOBAL TELEMETRY DEVICES FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 199 GLOBAL OTHERS FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 200 GLOBAL OTHERS FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 201 GLOBAL PORTABLE FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 202 GLOBAL PORTABLE FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 203 GLOBAL NON-PORTABLE FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 204 GLOBAL NON-PORTABLE FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 205 GLOBAL NON-INVASIVE FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 206 GLOBAL NON-INVASIVE FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 207 GLOBAL INVASIVE FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 208 GLOBAL INVASIVE FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 209 GLOBAL ANTEPARTUM FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 210 GLOBAL ANTEPARTUM FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 211 GLOBAL INTRAPARTUM FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 212 GLOBAL INTRAPARTUM FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 213 GLOBAL HOSPITALS FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 214 GLOBAL HOSPITALS FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 215 GLOBAL OBSTETRICS & GYNECOLOGY CLINICS FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 216 GLOBAL OBSTETRICS & GYNECOLOGY CLINICS FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 217 GLOBAL OTHERS FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 ($ MILLION)
TABLE 218 GLOBAL OTHERS FETAL MONITORING MARKET BY GEOGRAPHY 2023−2029 (%)
TABLE 219 CURRENCY CONVERSION 2016–2023
1. SCOPE & COVERAGE
1.1. MARKET DEFINITION
1.1.1. INCLUSIONS
1.1.2. EXCLUSIONS
1.1.3. MARKET ESTIMATION CAVEATS
1.2. SEGMENTS COVERED & DEFINITION
1.2.1. MARKET SEGMENTATION BY PRODUCT TYPE
1.2.2. MARKET SEGMENTATION BY PORTABILITY
1.2.3. MARKET SEGMENTATION BY METHOD
1.2.4. MARKET SEGMENTATION BY APPLICATION
1.2.5. MARKET SEGMENTATION BY END-USER
1.2.6. REGIONS & COUNTRIES COVERED
1.3. MARKET DERIVATION
1.3.1. HISTORIC, BASE, & FORECAST YEARS
2. PREMIUM INSIGHTS
2.1. OPPORTUNITY POCKETS
2.2. OVERVIEW
2.2.1. MARKET DYNAMICS
2.2.2. GEOGRAPHY INSIGHTS
2.2.3. PRODUCT TYPE INSIGHTS
2.2.4. PORTABILITY INSIGHTS
2.2.5. METHOD INSIGHTS
2.2.6. APPLICATION INSIGHTS
2.2.7. END-USER INSIGHTS
3. MARKET AT A GLANCE
4. INTRODUCTION
4.1. OVERVIEW
5. MARKET OPPORTUNITIES & TRENDS
5.1. INTEGRATION OF AI & ML IN FETAL MONITORING
5.2. GROWTH IN SIGNIFICANCE OF REMOTE FETAL MONITORING
5.3. GROWTH IN GOVERNMENT INITIATIVES & COLLABORATIONS FOR RESEARCH BY HEALTH AGENCIES
5.4. MANUFACTURERS FOCUS ON DEVELOPING PORTABLE, WIRELESS, AND ADVANCED FETAL MONITORS
6. MARKET GROWTH ENABLERS
6.1. GROWTH IN AWARENESS AND DEMAND FOR PRENATAL CARE
6.2. GROWTH IN ADVANCES & INNOVATIONS IN FETAL MONITORING TECHNOLOGIES
6.3. RISE IN NUMBER OF PRETERM BIRTHS & ADOPTION OF INFERTILITY TREATMENT
6.4. NEW PRODUCT LAUNCHES
7. MARKET RESTRAINTS
7.1. COMMON ERRORS IN FETAL HEART MONITORING
7.2. HIGH COST OF FETAL MONITORING EQUIPMENT
7.3. AVAILABILITY OF REFURBISHED EQUIPMENT
8. MARKET LANDSCAPE
8.1. MARKET OVERVIEW
8.2. MARKET SIZE & FORECAST
8.3. FIVE FORCES ANALYSIS
8.3.1. THREAT OF NEW ENTRANTS
8.3.2. BARGAINING POWER OF SUPPLIERS
8.3.3. BARGAINING POWER OF BUYERS
8.3.4. THREAT OF SUBSTITUTES
8.3.5. COMPETITIVE RIVALRY
9. PRODUCT TYPE
9.1. MARKET SNAPSHOT & GROWTH ENGINE
9.2. MARKET OVERVIEW
9.3. ULTRASOUND DEVICES
9.3.1. MARKET OVERVIEW
9.3.2. MARKET SIZE & FORECAST
9.3.3. MARKET BY GEOGRAPHY
9.4. ELECTRONIC MATERNAL/FETAL MONITORS
9.4.1. MARKET OVERVIEW
9.4.2. MARKET SIZE & FORECAST
9.4.3. MARKET BY GEOGRAPHY
9.5. FETAL ELECTRODES
9.5.1. MARKET OVERVIEW
9.5.2. MARKET SIZE & FORECAST
9.5.3. MARKET BY GEOGRAPHY
9.6. FETAL DOPPLER
9.6.1. MARKET OVERVIEW
9.6.2. MARKET SIZE & FORECAST
9.6.3. MARKET BY GEOGRAPHY
9.7. UTERINE CONTRACTION MONITORS
9.7.1. MARKET OVERVIEW
9.7.2. MARKET SIZE & FORECAST
9.7.3. MARKET BY GEOGRAPHY
9.8. TELEMETRY DEVICES
9.8.1. MARKET OVERVIEW
9.8.2. MARKET SIZE & FORECAST
9.8.3. MARKET BY GEOGRAPHY
9.9. OTHERS
9.9.1. MARKET OVERVIEW
9.9.2. MARKET SIZE & FORECAST
9.9.3. MARKET BY GEOGRAPHY
10. PORTABILITY
10.1. MARKET SNAPSHOT & GROWTH ENGINE
10.2. MARKET OVERVIEW
10.3. PORTABLE
10.3.1. MARKET OVERVIEW
10.3.2. MARKET SIZE & FORECAST
10.3.3. MARKET BY GEOGRAPHY
10.4. NON-PORTABLE
10.4.1. MARKET OVERVIEW
10.4.2. MARKET SIZE & FORECAST
10.4.3. MARKET BY GEOGRAPHY
11. METHOD
11.1. MARKET SNAPSHOT & GROWTH ENGINE
11.2. MARKET OVERVIEW
11.3. NON-INVASIVE
11.3.1. MARKET OVERVIEW
11.3.2. MARKET SIZE & FORECAST
11.3.3. MARKET BY GEOGRAPHY
11.4. INVASIVE
11.4.1. MARKET OVERVIEW
11.4.2. MARKET SIZE & FORECAST
11.4.3. MARKET BY GEOGRAPHY
12. APPLICATION
12.1. MARKET SNAPSHOT & GROWTH ENGINE
12.2. MARKET OVERVIEW
12.3. ANTEPARTUM
12.3.1. MARKET OVERVIEW
12.3.2. MARKET SIZE & FORECAST
12.3.3. MARKET BY GEOGRAPHY
12.4. INTRAPARTUM
12.4.1. MARKET OVERVIEW
12.4.2. MARKET SIZE & FORECAST
12.4.3. MARKET BY GEOGRAPHY
13. END-USER
13.1. MARKET SNAPSHOT & GROWTH ENGINE
13.2. MARKET OVERVIEW
13.3. HOSPITALS
13.3.1. MARKET OVERVIEW
13.3.2. MARKET SIZE & FORECAST
13.3.3. MARKET BY GEOGRAPHY
13.4. OBSTETRICS & GYNECOLOGY CLINICS
13.4.1. MARKET OVERVIEW
13.4.2. MARKET SIZE & FORECAST
13.4.3. MARKET BY GEOGRAPHY
13.5. OTHERS
13.5.1. MARKET OVERVIEW
13.5.2. MARKET SIZE & FORECAST
13.5.3. MARKET BY GEOGRAPHY
14. GEOGRAPHY
14.1. MARKET SNAPSHOT & GROWTH ENGINE
14.2. GEOGRAPHIC OVERVIEW
15. NORTH AMERICA
15.1. MARKET OVERVIEW
15.2. MARKET SIZE & FORECAST
15.2.1. PRODUCT TYPE
15.2.2. PORTABILITY
15.2.3. METHOD
15.2.4. APPLICATION
15.2.5. END-USER
15.3. KEY COUNTRIES
15.3.1. US: MARKET SIZE & FORECAST
15.3.2. CANADA: MARKET SIZE & FORECAST
16. EUROPE
16.1. MARKET OVERVIEW
16.2. MARKET SIZE & FORECAST
16.2.1. PRODUCT TYPE
16.2.2. PORTABILITY
16.2.3. METHOD
16.2.4. APPLICATION
16.2.5. END-USER
16.3. KEY COUNTRIES
16.3.1. GERMANY: MARKET SIZE & FORECAST
16.3.2. FRANCE: MARKET SIZE & FORECAST
16.3.3. UK: MARKET SIZE & FORECAST
16.3.4. ITALY: MARKET SIZE & FORECAST
16.3.5. SPAIN: MARKET SIZE & FORECAST
16.3.6. RUSSIA: MARKET SIZE & FORECAST
16.3.7. NETHERLANDS: MARKET SIZE & FORECAST
17. APAC
17.1. MARKET OVERVIEW
17.2. MARKET SIZE & FORECAST
17.2.1. PRODUCT TYPE
17.2.2. PORTABILITY
17.2.3. METHOD
17.2.4. APPLICATION
17.2.5. END-USER
17.3. KEY COUNTRIES
17.3.1. CHINA: MARKET SIZE & FORECAST
17.3.2. JAPAN: MARKET SIZE & FORECAST
17.3.3. INDIA: MARKET SIZE & FORECAST
17.3.4. SOUTH KOREA: MARKET SIZE & FORECAST
17.3.5. AUSTRALIA: MARKET SIZE & FORECAST
18. LATIN AMERICA
18.1. MARKET OVERVIEW
18.2. MARKET SIZE & FORECAST
18.2.1. PRODUCT TYPE
18.2.2. PORTABILITY
18.2.3. METHOD
18.2.4. APPLICATION
18.2.5. END-USER
18.3. KEY COUNTRIES
18.3.1. BRAZIL: MARKET SIZE & FORECAST
18.3.2. MEXICO: MARKET SIZE & FORECAST
18.3.3. ARGENTINA: MARKET SIZE & FORECAST
18.3.4. COLOMBIA: MARKET SIZE & FORECAST
19. MIDDLE EAST & AFRICA
19.1. MARKET OVERVIEW
19.2. MARKET SIZE & FORECAST
19.2.1. PRODUCT TYPE
19.2.2. PORTABILITY
19.2.3. METHOD
19.2.4. APPLICATION
19.2.5. END-USER
19.3. KEY COUNTRIES
19.3.1. TURKEY: MARKET SIZE & FORECAST
19.3.2. SAUDI ARABIA: MARKET SIZE & FORECAST
19.3.3. SOUTH AFRICA: MARKET SIZE & FORECAST
19.3.4. UAE: MARKET SIZE & FORECAST
20. COMPETITIVE LANDSCAPE
20.1. COMPETITION OVERVIEW
20.2. MARKET SHARE ANALYSIS
20.2.1. CARDINAL HEALTH
20.2.2. CONTEC MEDICAL SYSTEMS
20.2.3. GE HEALTHCARE
20.2.4. KONINKLIJKE PHILIPS
20.2.5. SIEMENS HEALTHINEERS
21. KEY COMPANY PROFILES
21.1. CARDINAL HEALTH
21.1.1. BUSINESS OVERVIEW
21.1.2. PRODUCT OFFERINGS
21.1.3. KEY STRATEGIES
21.1.4. KEY STRENGTHS
21.1.5. KEY OPPORTUNITIES
21.2. CONTEC MEDICAL SYSTEMS
21.2.1. BUSINESS OVERVIEW
21.2.2. PRODUCT OFFERINGS
21.2.3. KEY STRATEGIES
21.2.4. KEY STRENGTHS
21.2.5. KEY OPPORTUNITIES
21.3. GE HEALTHCARE
21.3.1. BUSINESS OVERVIEW
21.3.2. PRODUCT OFFERINGS
21.3.3. KEY STRATEGIES
21.3.4. KEY STRENGTHS
21.3.5. KEY OPPORTUNITIES
21.4. KONINKLIJKE PHILIPS
21.4.1. BUSINESS OVERVIEW
21.4.2. PRODUCT OFFERINGS
21.4.3. KEY STRATEGIES
21.4.4. KEY STRENGTHS
21.4.5. KEY OPPORTUNITIES
21.5. SIEMENS HEALTHINEERS
21.5.1. BUSINESS OVERVIEW
21.5.2. PRODUCT OFFERINGS
21.5.3. KEY STRATEGIES
21.5.4. KEY STRENGTHS
21.5.5. KEY OPPORTUNITIES
22. OTHER PROMINENT VENDORS
22.1. ADVANCED INSTRUMENTATIONS
22.1.1. BUSINESS OVERVIEW
22.1.2. PRODUCT OFFERINGS
22.2. ATOM MEDICAL
22.2.1. BUSINESS OVERVIEW
22.2.2. PRODUCT OFFERINGS
22.3. BIOLIGHT HEALTHCARE
22.3.1. BUSINESS OVERVIEW
22.3.2. PRODUCT OFFERINGS
22.4. BISTOS
22.4.1. BUSINESS OVERVIEW
22.4.2. PRODUCT OFFERINGS
22.5. BPL MEDICAL TECHNOLOGIES
22.5.1. BUSINESS OVERVIEW
22.5.2. PRODUCT OFFERINGS
22.6. BRAEL
22.6.1. BUSINESS OVERVIEW
22.6.2. PRODUCT OFFERINGS
22.7. CHOICEMMED
22.7.1. BUSINESS OVERVIEW
22.7.2. PRODUCT OFFERINGS
22.8. EDAN INSTRUMENTS
22.8.1. BUSINESS OVERVIEW
22.8.2. PRODUCT OFFERINGS
22.9. FRANCE CRÉATION & COMED
22.9.1. BUSINESS OVERVIEW
22.9.2. PRODUCT OFFERINGS
22.10. GENERAL MEDITECH
22.10.1. BUSINESS OVERVIEW
22.10.2. PRODUCT OFFERINGS
22.11. GIMA S.P.A.
22.11.1. BUSINESS OVERVIEW
22.11.2. PRODUCT OFFERINGS
22.12. GREATMADE TECH
22.12.1. BUSINESS OVERVIEW
22.12.2. PRODUCT OFFERINGS
22.13. HUNTLEIGH HEALTHCARE
22.13.1. BUSINESS OVERVIEW
22.13.2. PRODUCT OFFERINGS
22.14. JUMPER
22.14.1. BUSINESS OVERVIEW
22.14.2. PRODUCT OFFERINGS
22.15. MEDGYN PRODUCTS
22.15.1. BUSINESS OVERVIEW
22.15.2. PRODUCT OFFERINGS
22.16. MEDI WAVES
22.16.1. BUSINESS OVERVIEW
22.16.2. PRODUCT OFFERINGS
22.17. MEDIANA
22.17.1. BUSINESS OVERVIEW
22.17.2. PRODUCT OFFERINGS
22.18. MEDICAL ECONET
22.18.1. BUSINESS OVERVIEW
22.18.2. PRODUCT OFFERINGS
22.19. MEDITECH EQUIPMENT
22.19.1. BUSINESS OVERVIEW
22.19.2. PRODUCT OFFERINGS
22.20. MORETTI S.P.A.
22.20.1. BUSINESS OVERVIEW
22.20.2. PRODUCT OFFERINGS
22.21. NARANG MEDICAL
22.21.1. BUSINESS OVERVIEW
22.21.2. PRODUCT OFFERINGS
22.22. NEWMAN MEDICAL
22.22.1. BUSINESS OVERVIEW
22.22.2. PRODUCT OFFERINGS
22.23. PROMED TECHNOLOGY
22.23.1. BUSINESS OVERVIEW
22.23.2. PRODUCT OFFERINGS
22.24. PROMISE TECHNOLOGY
22.24.1. BUSINESS OVERVIEW
22.24.2. PRODUCT OFFERINGS
22.25. SHENZHEN AEON TECHNOLOGY
22.25.1. BUSINESS OVERVIEW
22.25.2. PRODUCT OFFERINGS
22.26. SHENZHEN BESTMAN INSTRUMENT
22.26.1. BUSINESS OVERVIEW
22.26.2. PRODUCT OFFERINGS
22.27. SHENZHEN LUCKCOME TECHNOLOGY
22.27.1. BUSINESS OVERVIEW
22.27.2. PRODUCT OFFERINGS
22.28. SHENZHEN UNICARE ELECTRONIC
22.28.1. BUSINESS OVERVIEW
22.28.2. PRODUCT OFFERINGS
22.29. SPENGLER HOLTEX GROUP
22.29.1. BUSINESS OVERVIEW
22.29.2. PRODUCT OFFERINGS
22.30. SURGITEK
22.30.1. BUSINESS OVERVIEW
22.30.2. PRODUCT OFFERINGS
22.31. TECHNOCARE MEDISYSTEMS
22.31.1. BUSINESS OVERVIEW
22.31.2. PRODUCT OFFERINGS
22.32. THE COOPER COMPANIES
22.32.1. BUSINESS OVERVIEW
22.32.2. PRODUCT OFFERING
22.33. TOITU
22.33.1. BUSINESS OVERVIEW
22.33.2. PRODUCT OFFERINGS
22.34. TRISMED
22.34.1. BUSINESS OVERVIEW
22.34.2. PRODUCT OFFERINGS
22.35. ULTRASOUND TECHNOLOGIES
22.35.1. BUSINESS OVERVIEW
22.35.2. PRODUCT OFFERINGS
22.36. YONKER
22.36.1. BUSINESS OVERVIEW
22.36.2. PRODUCT OFFERINGS
22.37. ZHENGZHOU DISON INSTRUMENT AND METER CO.
22.37.1. BUSINESS OVERVIEW
22.37.2. PRODUCT OFFERINGS
23. REPORT SUMMARY
23.1. KEY TAKEAWAYS
23.2. STRATEGIC RECOMMENDATIONS
24. QUANTITATIVE SUMMARY
24.1. MARKET BY PRODUCT TYPE
24.1.1. NORTH AMERICA
24.1.2. EUROPE
24.1.3. APAC
24.1.4. LATIN AMERICA
24.1.5. MIDDLE EAST & AFRICA
24.2. MARKET BY PORTABILITY
24.2.1. NORTH AMERICA
24.2.2. EUROPE
24.2.3. APAC
24.2.4. LATIN AMERICA
24.2.5. MIDDLE EAST & AFRICA
24.3. MARKET BY METHOD
24.3.1. NORTH AMERICA
24.3.2. EUROPE
24.3.3. APAC
24.3.4. LATIN AMERICA
24.3.5. MIDDLE EAST & AFRICA
24.4. MARKET BY APPLICATION
24.4.1. NORTH AMERICA
24.4.2. EUROPE
24.4.3. APAC
24.4.4. LATIN AMERICA
24.4.5. MIDDLE EAST & AFRICA
24.5. MARKET BY END-USER
24.5.1. NORTH AMERICA
24.5.2. EUROPE
24.5.3. APAC
24.5.4. LATIN AMERICA
24.5.5. MIDDLE EAST & AFRICA
24.6. MARKET BY GEOGRAPHY
24.7. PRODUCT TYPE
24.7.1. ULTRASOUND DEVICES
24.7.2. ELECTRONIC MATERNAL/FETAL MONITORS
24.7.3. FETAL ELECTRODES
24.7.4. FETAL DOPPLER
24.7.5. UTERINE CONTRACTION MONITORS
24.7.6. TELEMETRY DEVICES
24.7.7. OTHERS
24.8. PORTABILITY
24.8.1. PORTABLE
24.8.2. NON-PORTABLE
24.9. METHOD
24.9.1. NON-INVASIVE
24.9.2. INVASIVE
24.10. APPLICATION
24.10.1. ANTEPARTUM
24.10.2. INTRAPARTUM
24.11. END-USER
24.11.1. HOSPITALS
24.11.2. OBSTETRICS & GYNECOLOGY CLINICS
24.11.3. OTHERS
25. APPENDIX
25.1. RESEARCH METHODOLOGY
25.2. RESEARCH PROCESS
25.3. REPORT ASSUMPTIONS & CAVEATS
25.3.1. KEY CAVEATS
25.3.2. CURRENCY CONVERSION
26. ABBREVIATIONS
Select a license type that suits your business needs
Single User Licence
- Report accessible by one user only
- Free 10% or 3 days of customization
- Free post-sale service assistance
- Continuous support through email
5 User Licence
- Report accessible by 5 users within the organization
- Free 15% or 4.5 days of customization
- Continuous support through email and telephone
- Free analyst hour
- Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Corporate Licence
- Free Datasheet worth $1500
- Report accessible by the entire organization
- Free 20% or 6 days of customization
- Free post-sale service assistance
- Continuous support through email and telephone
- Direct access to lead analysts
- Free analyst hour
- Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Datasheet Licence
- Report accessible by 1 user only
- Free 15% or 32 hours of customization
- Free post-sale service assistance
- Direct access to lead analysts
Frequently Asked Questions
What is the growth rate of the global fetal monitoring market?
How big is the global fetal monitoring market?
Which region dominates the global fetal monitoring market share?
What are the significant trends in the fetal monitoring market?
Who are the key players in the global fetal monitoring market?
Other RELATED Reports
Global Refurbished Medical Equipment Market – Focused Insights 2024-2029
Published : September 2024